Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Offshore Selling to the Chinese: Time to Take It More Seriously As Healthcare Qu... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on latest developments in drug regulation, IP/legal issues a... (8/31/2017) Anti-monopoly Enforcement Trends in China's Healthcare Industry (9/13/2017) J&J Worldwide Pharma Chairman Joaquin Duato's Interview with China Daily: Serving in the Name of Progress (9/13/2017) China Liberalises Policy on Medical Institutions (9/13/2017) Regulatory Changes Position China as a Global Clinical Trial Destination (9/11/2017) Fosun Pharma Wants to Be the Xiaomi of China's Drug Industry (9/10/2017) Practical Guidance on License Agreement Recordal at SIPO (9/6/2017) Cross-Border HPV Vaccination Service Causes Controversy in China (9/4/2017) Why China's Traditional Medicine Boom Is Dangerous (9/1/2017) Offshore Selling to the Chinese: Time to Take It More Seriously As Healthcare Quality Fall and MNCs Head for the Exit? (8/31/2017) Chinese Patients Head to India for Latest Medicines after Domestic Crackdown (8/28/2017) Trump's Secret Weapon Against Unfair Trade Is the FCPA (8/28/2017) Asia Is the Fastest Growing Vaccine Market in the World (8/24/2017) Reimagining the Pharmaceutical Sales Rep Model in Asia (8/24/2017) The Great US-China Biotechnology and Artificial Intelligence Race (8/24/2017) China Proposes New Rules to Address Perceived Anti-Competitive Practices in The Pharmaceutical Industry (8/23/2017) Novo Nordisk Eyes Growth GLP-1 Diabetes ...  (9/22/2017) Zai Lab Launches IPO at Nasdaq with Impr...  (9/22/2017) (free) Ping An Insurance Buys 10% Stake of Japa...  (9/22/2017) Global Contract Pharmaceutical Manufactu...  (9/22/2017) Pfizer Appoints Creative Agency to Boost...  (9/22/2017) Krka to Set Up Chinese Joint Venture  (9/22/2017) Merck Opens China's First BioReliance En...  (9/22/2017) MNC Pharma Cos Face 'Triple Threats' in ...  (9/22/2017) Data Snapshot: Structural Review of Urba...  (9/22/2017) Data Snapshot: Structural Review of Coun...  (9/22/2017) Data Snapshot: Structural Review of Urba...  (9/22/2017) Data Snapshot: Structural Review of Urba...  (9/22/2017) China Approves New Hepatitis Medicines f...  (9/22/2017) CDE Issues New Technical Standards for G...  (9/22/2017) Bellen Raises CNY 250M in Series B Round...  (9/22/2017) Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA... Global Pharmerging Market to Grow at a CAGR of 12.88% in... Data Snapshot: Structural Review of Urban Community Healthcare ... Data Snapshot: Structural Review of County Level Public Hospita... Data Snapshot: Structural Review of Urban Public Hospital Drug ... Data Snapshot: Structural Review of Urban Retail Pharmacy Drug ... Roland Berger: Chinese Drug Retail Market to Grow 10-15% CAGR B... Novo Nordisk Eyes Growth GLP-1 Diabetes Drugs in Untapped Ch... Zai Lab Launches IPO at Nasdaq with Impressive Success Ping An Insurance Buys 10% Stake of Japanese TCM Co. Tsumura... Pfizer Appoints Creative Agency to Boost Viagra Publicity in... Krka to Set Up Chinese Joint Venture CDE Issues New Technical Standards for Generic Drug Equi... National MR Filing System under Development by the CFDA CFDA Solicits Comments on Draft Announcement for Amendme... CFDA Issues New Announcement (2017#109) for Clinical Dat... CFDA Issues Technical Guidelines for TCM Post Marketing ... CFDA Issues New Policy to Promote Translation of Scientific ... China Sets Up New IP Rights Center for Manufacturing and Bio... China Issues Interpretations for Application of Criminal Law... USTR Promises Thorough Investigation of China's IP Practices... China Moves Up to No. 22 in 2017 Global Innovation Index French Authority Warns Chongqing API Producer over GMP V... Another Chinese API Producer in Data Integrity Mudpool a... U.S. FDA Warns Chinese API Producer for Absence of Writt... India to Make Key APIs to Reduce Dependence on China DSM Sinochem Pharmaceuticals Boosts Manufacturing Capaci... Galectin Therapeutics To Be Granted Chinese Patent for I... BeiGene Presents Preliminary Phase 1 Data for BGB-A317 i... BeiGene Presents Preliminary Phase 1/2 Clinical Data on ... Yisheng Biopharma Announces Breakthrough Results on Immu... Chi-Med Initiates a Phase I Trial of Selective PI3Kδ In... China Sees Rising Incidence of Breast Cancer in Recent Y... China Sets Up The Changing Diabetes Foundation with Help... NHFPC Releases 2016 Annual Health and Family Planning Se... NHFPC and SATCM Issue Guiding Principles for Clinical Pa... Central Government Holds Promotional Conference for Medi... Recent Executive Moves Shang Yong Appointed Vice Minister of CFDA Recent Executive Moves Recent Executive Moves Recent Executive Moves EU Group Warns China to Make Good on Market Access Promi... Hays Poll: Job Seekers in China Prefer Personal Networki... UNAIDS Calls on China to Boost Drug Manufacturing in Afr... WiCON Publishes the China Pharmaceutical Guide 2017 (12t... Upcoming Event: Annual Biopharma Innovation Conference 2... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links